Senti Biosciences Holdings Capital Expenditures (CapEx) Growth & History (SNTI)
Senti Biosciences Holdings's capital expenditures (capex) was $196,000 for fiscal 2025.
View full Senti Biosciences Holdings company overviewSenti Biosciences Holdings annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $196,000 | $170,000 | +653.85% |
| 2024 | 2024-12-31 | $26,000 | −$12.0M | −99.78% |
| 2023 | 2023-12-31 | $12.0M | −$29.3M | −70.90% |
| 2022 | 2022-12-31 | $41.4M | $35.8M | +646.42% |
| 2021 | 2021-12-31 | $5.5M | — | — |
Senti Biosciences Holdings quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $0 | −$11,000 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $196,000 | $196,000 | — |
| Q1 2025 | 2025-03-31 | $0 | −$15,000 | — |
| Q4 2024 | 2024-12-31 | $11,000 | $7,000 | +175.00% |
| Q3 2024 | 2024-09-30 | $0 | −$1.9M | — |
| Q2 2024 | 2024-06-30 | $0 | −$3.7M | — |
| Q1 2024 | 2024-03-31 | $15,000 | −$6.5M | −99.77% |
| Q4 2023 | 2023-12-31 | $4,000 | −$8.5M | −99.95% |
| Q3 2023 | 2023-09-30 | $1.9M | −$12.3M | −86.92% |
| Q2 2023 | 2023-06-30 | $3.7M | −$7.6M | −67.42% |
| Q1 2023 | 2023-03-31 | $6.5M | −$873,000 | −11.83% |
| Q4 2022 | 2022-12-31 | $8.5M | — | — |
| Q3 2022 | 2022-09-30 | $14.2M | $13.3M | +1423.71% |
| Q2 2022 | 2022-06-30 | $11.3M | — | — |
| Q1 2022 | 2022-03-31 | $7.4M | — | — |
| Q3 2021 | 2021-09-30 | $932,000 | — | — |
Senti Biosciences Holdings capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Senti Biosciences Holdings's capital expenditures (capex) decreased from $5.5M to $196,000, a change of −$5.3M. The latest reported quarter, Q4 2025, shows $0.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Senti Biosciences Holdings source filings ↗